|
|
|
|
| LEADER |
00000cam a22000007a 4500 |
| 001 |
SCIDIR_on1381547888 |
| 003 |
OCoLC |
| 005 |
20231120010743.0 |
| 006 |
m o d |
| 007 |
cr un|---aucuu |
| 008 |
230610s2023 xx o 000 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|c YDX
|d OPELS
|d UKAHL
|d UKMGB
|d OCLCF
|d OCLCO
|
| 015 |
|
|
|a GBC3A2777
|2 bnb
|
| 016 |
7 |
|
|a 021070312
|2 Uk
|
| 019 |
|
|
|a 1389817448
|
| 020 |
|
|
|a 9780443186783
|q (electronic bk.)
|
| 020 |
|
|
|a 0443186782
|q (electronic bk.)
|
| 020 |
|
|
|z 9780443186776
|
| 020 |
|
|
|z 0443186774
|
| 035 |
|
|
|a (OCoLC)1381547888
|z (OCoLC)1389817448
|
| 050 |
|
4 |
|a QP606.P78
|
| 082 |
0 |
4 |
|a 612.01516
|2 23/eng/20230711
|
| 245 |
0 |
0 |
|a Receptor tyrosine kinases in neurodegenerative and psychiatric disorders /
|c edited by Heba Mohamed Mansour, Mahmoud Mohamed Khattab, Saad El-Khatib.
|
| 260 |
|
|
|a [S.l.] :
|b Academic Press,
|c 2023.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|2 rdacontent
|
| 337 |
|
|
|a computer
|2 rdamedia
|
| 338 |
|
|
|a online resource
|2 rdacarrier
|
| 650 |
|
0 |
|a Protein-tyrosine kinase
|x Receptors.
|
| 650 |
|
0 |
|a Nervous system
|x Degeneration
|x Treatment.
|
| 650 |
|
0 |
|a Mental illness
|x Treatment.
|
| 650 |
|
2 |
|a Mental Disorders
|x therapy
|0 (DNLM)D001523Q000628
|
| 650 |
|
6 |
|a Prot�eine-tyrosine kinase
|0 (CaQQLa)201-0292513
|x R�ecepteurs.
|0 (CaQQLa)201-0375415
|
| 650 |
|
6 |
|a Maladies mentales
|x Traitement.
|0 (CaQQLa)201-0198781
|
| 650 |
|
7 |
|a Mental illness
|x Treatment
|2 fast
|0 (OCoLC)fst01016606
|
| 650 |
|
7 |
|a Nervous system
|x Degeneration
|x Treatment
|2 fast
|0 (OCoLC)fst01036096
|
| 700 |
1 |
|
|a Mansour, Heba Mohamed.
|
| 776 |
0 |
8 |
|c Original
|z 0443186774
|z 9780443186776
|w (OCoLC)1368105688
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780443186776
|z Texto completo
|
